Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page revision indicator was updated to v3.5.4, signaling a new revision of the study record.SummaryDifference0.0%

- Check17 days agoChange DetectedThe Collaborators section now lists 'GOG Foundation' as a collaborator, replacing the previous entry 'GOG Foundation, Inc. (GOG Foundation)'.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page footer has been updated to reflect a new ClinicalTrials.gov site release version (revision v3.5.3 instead of v3.5.0).SummaryDifference0.0%

- Check67 days agoChange DetectedLocation listing updated from Napoli, Italy to Naples, Italy to reflect English naming conventions. Study results status changed from No Results Posted to Results Submitted.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page's revision history was updated to add Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.0%

- Check104 days agoChange DetectedRevision: v3.4.2 is now shown, replacing the previous v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.